Former Obama Health Official’s Claim Cuban’s Drug Company Won’t Lower Brand Prices Draws Rebuke From Cuban

By Maaisha Osman / July 31, 2024 at 5:30 PM
Mark Cuban, founder of the Mark Cuban Cost Plus Drug Company, tells Inside Health Policy that a former Obama administration health care adviser’s claim that Cuban’s company is unlikely to lower prices patients pay for brand-name drugs is inaccurate. The former adviser opined that Cuban’s main contribution is helping to alleviate the generic drug shortage, not lowering prices. Cuban says that Cost Plus is in the process of contracting with brand-name drug companies where the companies will make more...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.